1. Home
  2. PDFS vs XERS Comparison

PDFS vs XERS Comparison

Compare PDFS & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PDF Solutions Inc.

PDFS

PDF Solutions Inc.

N/A

Current Price

$33.53

Market Cap

1.3B

Sector

Technology

ML Signal

N/A

XERS

Xeris Biopharma Holdings Inc.

N/A

Current Price

$6.68

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PDFS
XERS
Founded
1992
2005
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
PDFS
XERS
Price
$33.53
$6.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
7
Target Price
$33.00
$10.43
AVG Volume (30 Days)
302.4K
1.4M
Earning Date
05-14-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
17.78
EPS
N/A
N/A
Revenue
N/A
$49,590,000.00
Revenue This Year
$21.58
$44.77
Revenue Next Year
$18.61
$27.72
P/E Ratio
N/A
N/A
Revenue Growth
N/A
142.67
52 Week Low
$15.91
$3.59
52 Week High
$36.99
$10.08

Technical Indicators

Market Signals
Indicator
PDFS
XERS
Relative Strength Index (RSI) 58.48 38.40
Support Level $26.91 $6.26
Resistance Level $35.13 $8.43
Average True Range (ATR) 1.71 0.26
MACD 0.25 -0.03
Stochastic Oscillator 88.39 36.00

Price Performance

Historical Comparison
PDFS
XERS

About PDFS PDF Solutions Inc.

PDF Solutions Inc offers products and services designed to empower engineers and data scientists across the semiconductor ecosystem to improve the yield, quality, and profitability of their products. The solutions combine proprietary software, physical intellectual property (or IP) for integrated circuit (or IC) designs, electrical measurement hardware tools, various methodologies, and professional services. The company's products and services are sold to integrated device manufacturers (or IDMs), fabless semiconductor companies, foundries, outsourced semiconductor assembly and test (or OSATs), and system houses.

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

Share on Social Networks: